167 related articles for article (PubMed ID: 9973519)
1. Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis.
McFarland HI; Lobito AA; Johnson MM; Nyswaner JT; Frank JA; Palardy GR; Tresser N; Genain CP; Mueller JP; Matis LA; Lenardo MJ
J Immunol; 1999 Feb; 162(4):2384-90. PubMed ID: 9973519
[TBL] [Abstract][Full Text] [Related]
2. Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination.
von Büdingen HC; Hauser SL; Ouallet JC; Tanuma N; Menge T; Genain CP
Eur J Immunol; 2004 Aug; 34(8):2072-83. PubMed ID: 15259004
[TBL] [Abstract][Full Text] [Related]
3. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
[TBL] [Abstract][Full Text] [Related]
4. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
Genain CP; Nguyen MH; Letvin NL; Pearl R; Davis RL; Adelman M; Lees MB; Linington C; Hauser SL
J Clin Invest; 1995 Dec; 96(6):2966-74. PubMed ID: 8675668
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55.
Ichikawa M; Johns TG; Liu J; Bernard CC
J Immunol; 1996 Jul; 157(2):919-26. PubMed ID: 8752946
[TBL] [Abstract][Full Text] [Related]
6. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
[TBL] [Abstract][Full Text] [Related]
7. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats.
Sakuma H; Kohyama K; Park IK; Miyakoshi A; Tanuma N; Matsumoto Y
Brain; 2004 Oct; 127(Pt 10):2201-13. PubMed ID: 15282218
[TBL] [Abstract][Full Text] [Related]
9. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
Genain CP; Cannella B; Hauser SL; Raine CS
Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
[TBL] [Abstract][Full Text] [Related]
10. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
Massacesi L; Genain CP; Lee-Parritz D; Letvin NL; Canfield D; Hauser SL
Ann Neurol; 1995 Apr; 37(4):519-30. PubMed ID: 7717689
[TBL] [Abstract][Full Text] [Related]
11. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.
Hjelmström P; Juedes AE; Fjell J; Ruddle NH
J Immunol; 1998 Nov; 161(9):4480-3. PubMed ID: 9794370
[TBL] [Abstract][Full Text] [Related]
12. Marmoset fine B cell and T cell epitope specificities mapped onto a homology model of the extracellular domain of human myelin oligodendrocyte glycoprotein.
Mesleh MF; Belmar N; Lu CW; Krishnan VV; Maxwell RS; Genain CP; Cosman M
Neurobiol Dis; 2002 Mar; 9(2):160-72. PubMed ID: 11895369
[TBL] [Abstract][Full Text] [Related]
13. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
[TBL] [Abstract][Full Text] [Related]
14. Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey.
Merkler D; Böscke R; Schmelting B; Czéh B; Fuchs E; Brück W; Stadelmann C
Brain Pathol; 2006 Apr; 16(2):117-23. PubMed ID: 16768751
[TBL] [Abstract][Full Text] [Related]
15. Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA.
Menge T; von Büdingen HC; Lalive PH; Genain CP
Eur J Immunol; 2007 Nov; 37(11):3229-39. PubMed ID: 17918203
[TBL] [Abstract][Full Text] [Related]
16. Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies.
Abo S; Bernard CC; Webb M; Johns TG; Alafaci A; Ward LD; Simpson RJ; Kerlero de Rosbo N
Biochem Mol Biol Int; 1993 Aug; 30(5):945-58. PubMed ID: 8220243
[TBL] [Abstract][Full Text] [Related]
17. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
[TBL] [Abstract][Full Text] [Related]
18. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
19. Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete freund adjuvant.
Jagessar SA; Kap YS; Heijmans N; van Driel N; van Straalen L; Bajramovic JJ; Brok HP; Blezer EL; Bauer J; Laman JD; 't Hart BA
J Neuropathol Exp Neurol; 2010 Apr; 69(4):372-85. PubMed ID: 20448482
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
